Patents by Inventor RYAN O. EMERSON

RYAN O. EMERSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220298575
    Abstract: Disclosed are methods for determining the immunological status of the adaptive immune system of a subject by identifying and quantifying rearranged DNA (and/or subsequently transcribed RNA) sequences encoding T cell receptor (TCR) and/or immunoglobulin (IG) polypeptides, in a lymphoid DNA-containing sample from the subject. TCR and/or IG sequence diversity and sequence distribution permit immunocompetence and immune repertoire assessment and reflect the degree of T cell or B cell clonality and clonal expansion in the sample. Methods for stratifying patient populations on the basis of immunocompetence including likelihood of responding to immunotherapy are also described.
    Type: Application
    Filed: November 18, 2021
    Publication date: September 22, 2022
    Inventors: Harlan S. Robins, Julie Rubinstein, Ryan O. Emerson, Jianda Yuan
  • Patent number: 11254980
    Abstract: Methods and compositions are provided for quantifying the number of biological input molecules of one or more target genes of interest in a PCR. The method comprises steps for amplifying multiple synthetic templates and high throughput sequencing. The method further comprises steps for achieving equal sequencing coverage between targets that do not occur in equal ratios, while mitigating the need for costly deep sequencing methods.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: February 22, 2022
    Assignee: Adaptive Biotechnologies Corporation
    Inventors: Ryan O. Emerson, Anna M. Sherwood, Harlan S. Robins
  • Patent number: 11248253
    Abstract: Methods are provided for correction of amplification bias and quantitation of adaptive immune cells in a sample using synthetic templates that include random oligonucleotide sequences.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: February 15, 2022
    Assignee: Adaptive Biotechnologies Corporation
    Inventors: Anna M. Sherwood, Ryan O. Emerson, Harlan S. Robins, Mark J. Rieder, Joe Parsons
  • Publication number: 20210381050
    Abstract: Methods are provided for predicting a subject's infection status using high-throughput T cell receptor sequencing to match the subject's TCR repertoire to a known set of disease-associated T cell receptor sequences. The methods of the present invention may be used to predict the status of several infectious agents in a single sample from a subject. Methods are also provided for predicting a subject's HLA status using high-throughput immune receptor sequencing.
    Type: Application
    Filed: June 9, 2021
    Publication date: December 9, 2021
    Inventors: Ryan O. Emerson, Harlan S. Robins, Mark J. Rieder, William S. Dewitt, III, Christopher S. Carlson
  • Patent number: 11066705
    Abstract: Methods of monitoring and measuring dynamic adaptive immune cell responses are provided. High-throughput sequencing of T cell receptor and immunoglobulin loci is used to characterize the breadth of an effector cell response to a stimulus, such as a vaccine or infection. Unique responding effector cell clones and abundance thereof can be determined. Additionally, methods for determining the contribution of responding effector cells to the immunological memory compartment are provided.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: July 20, 2021
    Assignees: Adaptive Biotechnologies Corporation, Fred Hutchinson Cancer Research Center
    Inventors: Harlan S. Robins, William Sumner DeWitt, III, Ryan O. Emerson
  • Patent number: 11047008
    Abstract: Methods are provided for predicting a subject's infection status using high-throughput T cell receptor sequencing to match the subject's TCR repertoire to a known set of disease-associated T cell receptor sequences. The methods of the present invention may be used to predict the status of several infectious agents in a single sample from a subject. Methods are also provided for predicting a subject's HLA status using high-throughput immune receptor sequencing.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: June 29, 2021
    Assignees: Adaptive Biotechnologies Corporation, Fred Hutchinson Cancer Research Center
    Inventors: Ryan O. Emerson, Harlan S. Robins, Mark Rieder, William Dewitt, III, Christopher Carlson
  • Patent number: 10894977
    Abstract: Compositions and methods are described for standardizing the DNA amplification efficiencies of a highly heterogeneous set of oligonucleotide primers as may typically be used to amplify a heterogeneous set of DNA templates that contains rearranged lymphoid cell DNA encoding T cell receptors (TCR) or immunoglobulins (IG). The presently disclosed embodiments are useful to overcome undesirable bias in the utilization of a subset of amplification primers, which leads to imprecision in multiplexed high throughput sequencing of amplification products to quantify unique TCR or Ig encoding genomes in a sample. Provided is a template composition comprising a diverse plurality of template oligonucleotides in substantially equimolar amounts, for use as a calibration standard for amplification primer sets. Also provided are methods for identifying and correcting biased primer efficiency during amplification.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: January 19, 2021
    Assignee: Adaptive Biotechnologies corporation
    Inventors: Harlan Saul Robins, Christopher Scott Carlson, Robert J. Livingston, Ryan O. Emerson, Anna M. Sherwood
  • Publication number: 20200325526
    Abstract: Methods are provided for correction of amplification bias and quantitation of adaptive immune cells in a sample using synthetic templates that include random oligonucleotide sequences.
    Type: Application
    Filed: May 1, 2020
    Publication date: October 15, 2020
    Inventors: Anna M. SHERWOOD, Ryan O. EMERSON, Harlan S. ROBINS, Mark J. RIEDER, Joe PARSONS
  • Patent number: 10392663
    Abstract: The invention is directed to methods for highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune heterodimers from a large number of biological samples containing lymphocytes of interest. Methods of the invention comprise performing a single pairing assay on a pool of source samples to determine nucleic acids encoding paired cognate receptor heterodimer chains in the combined pool. Separately, single-locus, high-throughput sequencing is performed on each individual sample to determine the plurality of sequences encoding one of the two receptor polypeptide chains. Pairs of cognate sequences determined in the pooled sample may then be mapped back to a single source sample by comparing the expression patterns of the single-locus sequences.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: August 27, 2019
    Assignees: ADAPTIVE BIOTECHNOLOGIES CORP., FRED HUTCHINSON CANCER RESEARCH CENTER
    Inventors: Ryan O. Emerson, Anna M. Sherwood, Harlan S. Robins
  • Publication number: 20190203281
    Abstract: Compositions and methods are described for standardizing the DNA amplification efficiencies of a highly heterogeneous set of oligonucleotide primers as may typically be used to amplify a heterogeneous set of DNA templates that contains rearranged lymphoid cell DNA encoding T cell receptors (TCR) or immunoglobulins (IG). The presently disclosed embodiments are useful to overcome undesirable bias in the utilization of a subset of amplification primers, which leads to imprecision in multiplexed high throughput sequencing of amplification products to quantify unique TCR or Ig encoding genomes in a sample. Provided is a template composition comprising a diverse plurality of template oligonucleotides in substantially equimolar amounts, for use as a calibration standard for amplification primer sets. Also provided are methods for identifying and correcting biased primer efficiency during amplification.
    Type: Application
    Filed: January 8, 2019
    Publication date: July 4, 2019
    Inventors: Harlan Saul ROBINS, Christopher Scott CARLSON, Robert J. LIVINGSTON, Ryan O. EMERSON, Anna M. SHERWOOD
  • Patent number: 10246701
    Abstract: The invention relates to methods and compositions for estimating the absolute abundance individually for each unique rearranged lymphocyte receptor in a mixed sample.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: April 2, 2019
    Assignee: ADAPTIVE BIOTECHNOLOGIES CORP.
    Inventors: William S Dewitt, Ryan O Emerson, Harlan S Robins, Anna M Sherwood
  • Patent number: 10214770
    Abstract: Compositions and methods are described for standardizing the DNA amplification efficiencies of a highly heterogeneous set of oligonucleotide primers as may typically be used to amplify a heterogeneous set of DNA templates that contains rearranged lymphoid cell DNA encoding T cell receptors (TCR) or immunoglobulins (IG). The presently disclosed embodiments are useful to overcome undesirable bias in the utilization of a subset of amplification primers, which leads to imprecision in multiplexed high throughput sequencing of amplification products to quantify unique TCR or Ig encoding genomes in a sample. Provided is a composition comprising a diverse plurality of template oligonucleotides in substantially equimolar amounts, for use as a calibration standard for amplification primer sets. Also provided are methods for identifying and correcting biased primer efficiency during amplification.
    Type: Grant
    Filed: May 10, 2016
    Date of Patent: February 26, 2019
    Assignee: ADAPTIVE BIOTECHNOLOGIES CORP.
    Inventors: Harlan Saul Robins, Christopher Scott Carlson, Robert J. Livingston, Ryan O. Emerson, Anna M. Sherwood
  • Patent number: 10150996
    Abstract: A relative representation of adaptive immune cells in a biological sample is quantified using multiplex PCR and sequencing of adaptive immune cells, control genes, and synthetic template molecules. Disclosed herein are methods for quantifying a number of adaptive immune cells in a biological sample, and methods for quantifying a relative representation of adaptive immune cells in a biological sample that comprises a mixture of cells comprising adaptive immune cells and cells that are not adaptive immune cells. Methods are provided for amplifying by multiplex PCR and sequencing a first set of synthetic templates each comprising one TCR or IgV segment and one TCR of Ig J or C segment and a unique bar code.
    Type: Grant
    Filed: March 5, 2015
    Date of Patent: December 11, 2018
    Assignee: ADAPTIVE BIOTECHNOLOGIES CORP.
    Inventors: Harlan Saul Robins, Christopher Scott Carlson, Mark J. Rieder, Anna M. Sherwood, Ryan O. Emerson
  • Publication number: 20180037953
    Abstract: Methods are provided for predicting a subject's infection status using high-throughput T cell receptor sequencing to match the subject's TCR repertoire to a known set of disease-associated T cell receptor sequences. The methods of the present invention may be used to predict the status of several infectious agents in a single sample from a subject. Methods are also provided for predicting a subject's HLA status using high-throughput immune receptor sequencing.
    Type: Application
    Filed: February 24, 2016
    Publication date: February 8, 2018
    Inventors: Ryan O. Emerson, Harlan S. Robins, Mark Rieder, William Dewitt, III, Christopher Carlson
  • Publication number: 20170362653
    Abstract: Methods of monitoring and measuring dynamic adaptive immune cell responses are provided. High-throughput sequencing of T cell receptor and immunoglobulin loci is used to characterize the breadth of an effector cell response to a stimulus, such as a vaccine or infection. Unique responding effector cell clones and abundance thereof can be determined. Additionally, methods for determining the contribution of responding effector cells to the immunological memory compartment are provided.
    Type: Application
    Filed: November 24, 2015
    Publication date: December 21, 2017
    Inventors: Harlan S. Robins, William Sumner DeWitt, III, Ryan O. Emerson
  • Publication number: 20170335391
    Abstract: The invention is directed to methods for highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune heterodimers from a large number of biological samples containing lymphocytes of interest. Methods of the invention comprise performing a single pairing assay on a pool of source samples to determine nucleic acids encoding paired cognate receptor heterodimer chains in the combined pool. Separately, single-locus, high-throughput sequencing is performed on each individual sample to determine the plurality of sequences encoding one of the two receptor polypeptide chains. Pairs of cognate sequences determined in the pooled sample may then be mapped back to a single source sample by comparing the expression patterns of the single-locus sequences.
    Type: Application
    Filed: October 29, 2015
    Publication date: November 23, 2017
    Inventors: Ryan O. EMERSON, Anna M. SHERWOOD, Harlan S. ROBINS
  • Publication number: 20170292149
    Abstract: Methods are provided for correction of amplification bias and quantitation of adaptive immune cells in a sample using synthetic templates that include random oligonucleotide sequences.
    Type: Application
    Filed: March 5, 2015
    Publication date: October 12, 2017
    Inventors: Anna M. SHERWOOD, Ryan O. EMERSON, Harlan S. ROBINS, Mark J. RIEDER, Joe PARSONS
  • Publication number: 20170037469
    Abstract: A relative representation of adaptive immune cells in a biological sample is quantified using multiplex PCR and sequencing of adaptive immune cells, control genes, and synthetic template molecules. Disclosed herein are methods for quantifying a number of adaptive immune cells in a biological sample, and methods for quantifying a relative representation of adaptive immune cells in a biological sample that comprises a mixture of cells comprising adaptive immune cells and cells that are not adaptive immune cells. Methods are provided for amplifying by multiplex PCR and sequencing a first set of synthetic templates each comprising one TCR or IgV segment and one TCR of Ig J or C segment and a unique bar code.
    Type: Application
    Filed: March 5, 2015
    Publication date: February 9, 2017
    Inventors: Harlan Saul ROBINS, Christopher Scott CARLSON, Mark J. RIEDER, Anna M. SHERWOOD, Ryan O. EMERSON
  • Publication number: 20160340729
    Abstract: Methods are provided for predicting and determining a subject's immune response to allograft. Methods include assessing immune response to an allograft by characterizing the diversity and distribution of clones of the adaptive immune repertoire. Methods are also provided for characterizing the adaptive immune response of a subject to an allograft using a mixed lymphocyte reaction culture.
    Type: Application
    Filed: January 9, 2015
    Publication date: November 24, 2016
    Inventors: Ryan O. Emerson, Ilan Kirsch, James Mathew, Joseph Leventhal
  • Publication number: 20160319340
    Abstract: Compositions and methods are described for standardizing the DNA amplification efficiencies of a highly heterogeneous set of oligonucleotide primers as may typically be used to amplify a heterogeneous set of DNA templates that contains rearranged lymphoid cell DNA encoding T cell receptors (TCR) or immunoglobulins (IG). The presently disclosed embodiments are useful to overcome undesirable bias in the utilization of a subset of amplification primers, which leads to imprecision in multiplexed high throughput sequencing of amplification products to quantify unique TCR or Ig encoding genomes in a sample. Provided is a composition comprising a diverse plurality of template oligonucleotides in substantially equimolar amounts, for use as a calibration standard for amplification primer sets. Also provided are methods for identifying and correcting biased primer efficiency during amplification.
    Type: Application
    Filed: May 10, 2016
    Publication date: November 3, 2016
    Inventors: Harlan Saul Robins, Christopher Scott Carlson, Robert J. Livingston, Ryan O. Emerson, Anna M. Sherwood